The Efficacy and Safety of Seladelpar for Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis
ABSTRACT Background and Objective Seladelpar is an oral, once‐daily medication that improves cholestasis through its selective peroxisome proliferator‐activated receptor (PPAR‐δ) agonism. It shows promising efficacy in treating primary biliary cholangitis (PBC) patients. Methods A systematic review...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2025-09-01
|
| Col·lecció: | JGH Open |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/jgh3.70265 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|